GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 52 filers reported holding GEMINI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,014,000 | +169.0% | 2,447,477 | +177.3% | 0.01% | +233.3% |
| Q2 2022 | $1,492,000 | +21.6% | 882,612 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $1,227,000 | -38.2% | 882,612 | +29.3% | 0.00% | -50.0% |
| Q4 2021 | $1,986,000 | -35.1% | 682,612 | -9.9% | 0.00% | -33.3% |
| Q3 2021 | $3,061,000 | -46.4% | 757,612 | -14.2% | 0.01% | -45.5% |
| Q2 2021 | $5,710,000 | -53.2% | 882,612 | -1.9% | 0.01% | -56.0% |
| Q1 2021 | $12,195,000 | – | 900,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $9,838,000 | 3.06% |
| Asymmetry Capital Management, L.P. | 284,079 | $1,148,000 | 0.69% |
| Orbimed Advisors | 5,826,224 | $23,538,000 | 0.26% |
| Boxer Capital, LLC | 1,300,000 | $5,252,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,137,823 | $8,637,000 | 0.15% |
| Ikarian Capital, LLC | 421,050 | $1,701,000 | 0.12% |
| JS Capital Management LLC | 474,457 | $1,917,000 | 0.11% |
| PURA VIDA INVESTMENTS, LLC | 494,400 | $1,997,000 | 0.06% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,010,000 | 0.06% |
| Atom Investors LP | 102,792 | $415,000 | 0.03% |